PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



Lilly pledges $90 million 2016 10 18 IBJ .pdf


Original filename: Lilly pledges $90 million _ 2016-10-18 _ IBJ.pdf

This PDF 1.4 document has been generated by Mozilla/5.0 (Windows NT 6.1; WOW64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/54.0.2840.59 Safari/537.36 / Skia/PDF m54, and has been sent on pdf-archive.com on 19/10/2016 at 15:47, from IP address 50.79.x.x. The current document download page has been viewed 116 times.
File size: 141 KB (2 pages).
Privacy: public file




Download original PDF file









Document preview


Home

Lilly pledges $90 million to improve global drug
access
John Russell
October 18, 2016

Eli Lilly and Co. is pledging $90 million over five years to improve access to treatment for diabetes, cancer and
tuberculosis in developing countries—the latest push in its philanthropic strategy of building health care systems
around the world and increasing the market for its prescription drugs.
The Indianapolis­based drug maker said Tuesday the goal is improve health care for 30 million people annually
by 2030 in Brazil, China, India, Kenya, Mexico and other in “resource­limited settings.” That represents about a
six­fold increase in the number of people the company reaches annually, outside of its traditional businesses.
The company’s shorthand for the effort is “Lilly 30x30.”
“Over the past two decades, we have made tremendous progress in expanding access to quality care in poor
communities, but we can and must do more,” John Lechleiter, Lilly’s chairman and CEO, said in a written
statement.
One half of the $90 million will come from the Lilly Foundation and the other half will come from company
funds. Lilly and its foundation are separate from the Indianapolis­based Lilly Endowment, which is one of the
largest philanthropic organizations in Indiana.
The company will make the investment through its Lilly Global Health Partnership, a group of more than 45
international and national healthcare organizations, such as United Way Worldwide, the International Council of
Nurses and the Infectious Disease Research Institute.
As part of the effort, Lilly said it will explore new approaches within its company to help developing nations,
including boosting drug discovery for diseases disproportionately affecting poor people and increasing patient
education programs.

The 30x30 effort is the latest example of Lilly’s philanthropic strategy, which is to improve health worldwide
while paving the way for new customers for its drugs. In recent years, the company has spent tens of millions of
dollars and sent teams of employees as volunteers to improve health care systems in emerging markets such as
India and South Africa.
The company has acknowledged that helping countries take better care of people with chronic diseases such as
diabetes will  not only improve their health, but could also boost the number of patients taking Lilly’s diabetes
medicines.
In 2003, the company launched what has become a $170 million commitment—the largest philanthropic project
in its history—in which it gave the manufacturing know­how it had developed making antibiotics to more than
20 organizations globally so they could produce drugs for multi­drug­resistant tuberculosis.
The company has also sent doctors, pharmacists, diabetes educators and communications specialists to help
clinics and patients overseas, often in countries that lack electricity, clean water and sanitation.
 


Lilly pledges $90 million _ 2016-10-18 _ IBJ.pdf - page 1/2
Lilly pledges $90 million _ 2016-10-18 _ IBJ.pdf - page 2/2

Related documents


lilly pledges 90 million 2016 10 18 ibj
lilly buying developer of pain
eli lilly chasing psoriasis jackpot with taltz
after rough november some good news for lilly
focus biosciences institute s chief scientific officer
as pricing criticism mounts lilly


Related keywords